A biopharmaceutical company focused on developing treatments for central nervous system disorders, including depression and other brain health conditions. Its portfolio includes Zulresso for postpartum depression and drug candidates such as zuranolone developed in partnership with Biogen. Investors ...
4 members of Congress have disclosed 12 trades in Sage Therapeutics Inc (SAGE), a Healthcare company. The buy/sell breakdown shows 6 purchases versus 6 sales. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
| Date | Politician | Type | Amount |
|---|---|---|---|
| 2023-01-20 | Rohit Khanna | sell | $1K – $15K |
| 2023-01-20 | Rohit Khanna | sell | $1K – $15K |
| 2023-01-20 | Rohit Khanna | sell | $1K – $15K |
| 2020-02-27 | MICHAEL T. MCCAUL | sell | $1K – $15K |
| 2017-11-03 | JAMES B. RENACCI | sell | $1K – $15K |
| 2017-09-12 | JAMES B. RENACCI | buy | $1K – $15K |
| 2017-04-04 | JOHN K. DELANEY | buy | $15K – $50K |
| 2016-08-03 | JAMES B. RENACCI | buy | $15K – $50K |
| 2016-01-14 | JAMES B. RENACCI | buy | $15K – $50K |
| 2015-12-09 | JAMES B. RENACCI | sell | $15K – $50K |
| 2015-06-18 | JAMES B. RENACCI | buy | $1K – $15K |
| 2015-03-25 | JAMES B. RENACCI | buy | $50K – $100K |